XML 63 R50.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Related Party Transactions (Details Textual) - USD ($) | 1 Months Ended | 12 Months Ended |  |  |  |  |  |  |  |
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Nov. 18, 2016 | Dec. 31, 2016 | Dec. 31, 2012 | Dec. 31, 2018 | Oct. 31, 2018 | Oct. 10, 2018 | Sep. 05, 2018 | Dec. 31, 2017 | Aug. 07, 2015 | Aug. 31, 2012 | Nov. 30, 2011
Related Party Transaction [Line Items] |  |  |  |  |  |  |  |  |  |  |
Common Stock, Shares, Issued |  |  |  | 15,484,411 |  |  |  | 3,673,342 |  |  |
Common Stock, Value, Issued |  |  |  | $ 15,000 |  |  |  | $ 4,000 |  |  |
Common Stock, Par or Stated Value Per Share |  |  |  | $ (0.001) |  | $ (0.001) |  | $ (0.001) |  |  |
Class of Warrant or Right, Number of Securities Called by Warrants or Rights |  |  |  |  |  | 13,672,173 |  |  |  |  |
Class of Warrant or Right, Exercise Price of Warrants or Rights |  |  |  |  | $ 1.38 | $ 1.38 |  |  |  |  |
Synthetic Biomics Inc [Member] |  |  |  |  |  |  |  |  |  |  |
Related Party Transaction [Line Items] |  |  |  |  |  |  |  |  |  |  |
Additional Number Of Common Stock To Be Issued |  |  |  |  |  |  | 2,420,000 |  |  |  |
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners |  |  |  |  |  |  | (17.00%) |  |  |  |
Series A Warrant [Member] |  |  |  |  |  |  |  |  |  |  |
Related Party Transaction [Line Items] |  |  |  |  |  |  |  |  |  |  |
Class of Warrant or Right, Exercisable period | 4 years |  |  |  |  |  |  |  |  |  |
Series B Warrant [Member] |  |  |  |  |  |  |  |  |  |  |
Related Party Transaction [Line Items] |  |  |  |  |  |  |  |  |  |  |
Proceeds from Issuance of Common Stock | $ 8,572 |  |  |  |  |  |  |  |  |  |
Cedars-Sinai Medical Center [Member] |  |  |  |  |  |  |  |  |  |  |
Related Party Transaction [Line Items] |  |  |  |  |  |  |  |  |  |  |
Number Of Common Stock To Be Issued |  |  |  |  |  |  | 50,000 |  |  |  |
Revenue recogntion milestone method payments |  | $ 350,000 |  |  |  |  |  |  |  |  |
Cedars-Sinai Medical Center [Member] | Synthetic Biomics Inc [Member] |  |  |  |  |  |  |  |  |  |  |
Related Party Transaction [Line Items] |  |  |  |  |  |  |  |  |  |  |
Additional Number Of Common Stock To Be Issued |  |  |  |  |  |  | 2,420,000 |  |  |  |
Number Of Common Stock To Be Held By Related Party |  |  |  |  |  |  | 7,480,000 |  |  |  |
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners |  |  |  |  |  |  | (17.00%) |  |  |  |
Scott Tarriff [Member] |  |  |  |  |  |  |  |  |  |  |
Related Party Transaction [Line Items] |  |  |  |  |  |  |  |  |  |  |
Stock Issued During Period, Shares, Issued for Services | 8,572 |  |  |  |  |  |  |  |  |  |
Scott Tarriff [Member] | Series A Warrant [Member] |  |  |  |  |  |  |  |  |  |  |
Related Party Transaction [Line Items] |  |  |  |  |  |  |  |  |  |  |
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 8,572 |  |  |  |  |  |  |  |  |  |
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 50.05 |  |  |  |  |  |  |  |  |  |
Scott Tarriff [Member] | Series B Warrant [Member] |  |  |  |  |  |  |  |  |  |  |
Related Party Transaction [Line Items] |  |  |  |  |  |  |  |  |  |  |
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 8,572 |  |  |  |  |  |  |  |  |  |
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 60.20 |  |  |  |  |  |  |  |  |  |
Class of Warrant or Right, Date to which Warrants or Rights Exercisable | Dec. 31, 2017 |  |  |  |  |  |  |  |  |  |
Intrexon [Member] |  |  |  |  |  |  |  |  |  |  |
Related Party Transaction [Line Items] |  |  |  |  |  |  |  |  |  |  |
Common Stock, Shares, Issued |  |  |  |  |  |  |  |  | 26,785 | 101,492 | 89,245
Common Stock, Value, Issued |  |  |  |  |  |  |  |  | $ 3,000,000 | $ 7,800,000 | $ 1,700,000
Common Stock, Par or Stated Value Per Share |  |  |  |  |  |  |  |  |  | $ (77) | $ (18.90)
Costs and Expenses, Related Party |  |  | $ 2,900,000 |  |  |  |  |  |  |  |

X
- Definition The additional number of common stock to be issued under stock purchase agreement. + References No definition available. + Details
Name: | syn_AdditionalNumberOfCommonStockToBeIssued
Namespace Prefix: | syn_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Date until the warrants or rights are exercisable, in CCYY-MM-DD format. + References No definition available. + Details
Name: | syn_ClassOfWarrantOrRightDateToWhichWarrantsOrRightsExercisable
Namespace Prefix: | syn_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | duration

X
- Definition Period the warrants or rights are exercisable. + References No definition available. + Details
Name: | syn_ClassOfWarrantOrRightExercisablePeriod
Namespace Prefix: | syn_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition The additional number of common stock to be held by the related party under stock purchase agreement. + References No definition available. + Details
Name: | syn_NumberOfCommonStockToBeHeldByRelatedParty
Namespace Prefix: | syn_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The number of common stock to be issued under stock purchase agreement. + References No definition available. + Details
Name: | syn_NumberOfCommonStockToBeIssued
Namespace Prefix: | syn_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount represents the value of milestones payments related to license agreement. + References No definition available. + Details
Name: | syn_RevenueRecogntionMilestoneMethodPayments
Namespace Prefix: | syn_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Exercise price per share or per unit of warrants or rights outstanding. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(i)(4)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 + Details
Name: | us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(i)(2)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 + Details
Name: | us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Face amount or stated value per share of common stock. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_CommonStockParOrStatedValuePerShare
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_CommonStockSharesIssued
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_CommonStockValue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Costs of sales and operating expenses for the period incurred from transactions with related parties. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.2) -URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227 + Details
Name: | us-gaap_CostsAndExpensesRelatedParty
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity. + References No definition available. + Details
Name: | us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners
Namespace Prefix: | us-gaap_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition The cash inflow from the additional capital contribution to the entity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 14 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3255-108585 + Details
Name: | us-gaap_ProceedsFromIssuanceOfCommonStock
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_RelatedPartyTransactionLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders. + References No definition available. + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesIssuedForServices
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_OwnershipAxis=syn_SyntheticBiomicsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=syn_SeriesWarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=syn_SeriesBWarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=syn_CedarssinaiMedicalCenterMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=syn_ScottTarriffMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=syn_IntrexonMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |